Related Experiment Video
Updated: Jul 17, 2025
07:55
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
11.9K
Endocytosis and Alzheimer's disease
Łukasz Zadka1, Marta Sochocka2, Naomi Hachiya3
1Division of Ultrastructural Research, Wroclaw Medical University, 50-368, Wroclaw, Poland.
Geroscience
|August 30, 2023
Summary
Alzheimer's disease (AD) involves endosomal abnormalities, impacting neuronal function and potentially driving disease progression. Understanding these cellular processes is key to unraveling AD pathogenesis.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, characterized by amyloid-β plaques and neurofibrillary tangles.
- The exact pathogenesis of AD remains elusive, with key hypotheses including amyloid cascade and tau hyperphosphorylation.
- Endocytosis is crucial for cellular functions like nutrient uptake and receptor signaling.
Purpose of the Study:
- To review current knowledge on the role of endosomal abnormalities in Alzheimer's disease.
- To explore the link between neuronal endosomal function and AD pathology.
- To discuss how endocytosis alterations may contribute to AD progression.
Main Methods:
- Review of genetic and biochemical studies.
- Analysis of research linking endosomal function to AD pathology.
- Discussion of current literature on endosomal abnormalities in AD.
Main Results:
- Evidence suggests a strong link between neuronal endosomal dysfunction and AD pathology.
- Endolysosomal abnormalities are implicated as a significant cause of neuronal damage in AD.
- Alterations in the endocytosis process correlate with changes in protein expression, potentially progressing AD.
Conclusions:
- Endosomal abnormalities are a critical factor in Alzheimer's disease pathogenesis.
- Dysregulation of endocytosis contributes to neuronal lesions and disease progression in AD.
- Further research into endosomal pathways may offer therapeutic targets for AD.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
01:22Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
01:28The Early Endosome: Endocytosis of Transferrin
3.3K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.3K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
03:03Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
01:45ER Retrieval Pathway
3.9K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.9K